Liechtenstein Times
SEE OTHER BRANDS

The latest news from Liechtenstein

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Liechtenstein Times.

Steering Committee of the WTO Fish Fund moves towards making the Fund operational
The Silent Killer Chemical

The Silent Killer Chemical

Country(Required)Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin...

Owner:  College of Naturopathic Medicine
WTO members consider four regional trade agreements
LCX Launches Groundbreaking Tokenized Bonds: A Revolution in Compliant Staking

LCX Launches Groundbreaking Tokenized Bonds: A Revolution in Compliant Staking

VADUZ, LIECHTENSTEIN , March 29, 2023 (GLOBE NEWSWIRE) -- The innovative offering bridges the gap between traditional finance and digital assets, providing a secure, compliant, and regulated investment opportunity for BTC, ETH, and the LCX Token....

Owner:  Jason Raznick
LCX Launches Groundbreaking Tokenized Bonds: A Revolution in Compliant Staking
Orphan designation: sotatercept Treatment of  pulmonary arterial hypertension, 09/12/2020 Positive

Orphan designation: sotatercept Treatment of pulmonary arterial hypertension, 09/12/2020 Positive

At the time of designation, pulmonary arterial hypertension affected approximately 1.4 in 10,000 people in the European Union (EU). This was equivalent to a total of around 73,000 people1, and is below the ceiling for orphan designation, which is...

Owner:  European Union
Orphan designation: Brentuximab vedotin Treatment of cutaneous T-cell lymphoma, 11/01/2012 Withdrawn

Orphan designation: Brentuximab vedotin Treatment of cutaneous T-cell lymphoma, 11/01/2012 Withdrawn

At the time of designation, CTCL affected less than 2.2 in 10,000 people in the European Union (EU). This was equivalent to a total of fewer than 112,000 people*, and is below the ceiling for orphan designation, which is 5 people in 10,000. This...

Owner:  European Union
Delivering the goods: an EU trade agenda for the next UK government

Delivering the goods: an EU trade agenda for the next UK government

The Labour Party’s red lines will restrict its ambitions for changing the EU-UK relationship, but if it forms a government it should push Brussels for concessions, particularly on trade in goods. The Labour Party seems likely to form a government...

Owner:  PubAffairs Bruxelles (Non-profit)
Russia’s war of aggression against Ukraine: comprehensive EU’s 14th package of sanctions cracks down on circumvention and adopts energy measures
SUMMER WEB3FEST 2024: A Resounding Success and a Glimpse into the Future
OSCE gathering strengthens criminal justice systems against trafficking of refugees from Ukraine

OSCE gathering strengthens criminal justice systems against trafficking of refugees from Ukraine

Amid the unprecedented number of Ukrainians who fled the war and emerging cases of human trafficking and exploitation involving refugees, a strong criminal justice response in the host countries has become more crucial than ever. To foster prompt...

Owner:  Organization for Security and Co-operation in Europe
New lobbyist registration / request login

New lobbyist registration / request login

Country: United States Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda...

Owner:  American Government
EBRD Board of Directors visit Montenegro and Kosovo

EBRD Board of Directors visit Montenegro and Kosovo

EBRD headquarters in Canary Wharf Representatives of the European Bank for Reconstruction and Development’s (EBRD) Board of Directors will visit Montenegro from 17 to 18 June 2024 and Kosovo from 19 to 21 June 2024. The two visits are part of a...

Owner:  73 countries & European Union
Review of painkiller metamizole started

Review of painkiller metamizole started

EMA has started a review of medicines containing the painkiller metamizole following concerns that the measures in place to minimise the known risk of agranulocytosis may not be effective enough. Metamizole-containing medicines are authorised in a...

Owner:  European Union
Does your tongue look like this?

Does your tongue look like this?

Country(Required)Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin...

Owner:  College of Naturopathic Medicine
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
LCX Gains Regulatory Approval For First 10 Million Euro Tokenized Bond

LCX Gains Regulatory Approval For First 10 Million Euro Tokenized Bond

Vaduz, Liechtenstein, Feb. 08, 2023 (GLOBE NEWSWIRE) -- LCX is the first company in the cryptocurrency industry to issue a fixed-yield-earning product (EURt7 tokenized bond) that is based on an approved securities prospectus. The EURt7 tokenized...

Owner:  Jason Raznick
LCX Gains Regulatory Approval For First 10 Million Euro Tokenized Bond
Cross-Border E-Commerce Site "WAFUU.COM" Now Supports Swedish, Totaling 21 Languages
Orphan designation: Sorafenib tosilate Treatment of follicular thyroid cancer, 13/11/2013 Expired

Orphan designation: Sorafenib tosilate Treatment of follicular thyroid cancer, 13/11/2013 Expired

At the time of designation, follicular thyroid cancer affected between 0.2 and 0.9 in 10,000 people in the European Union (EU). This was equivalent to a total of between 10,000 and 46,000 people*, and is below the ceiling for orphan designation,...

Owner:  European Union

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions